SCHEMBL20176739

SCHEMBL20176739

c1ccc(-c2c3ccccc3c(-c3ccc(-c4ccc5oc6ccccc6c5c4)nc3)c3ccccc23)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.41
MAPT P10636 2/20 0.41
HPGD P15428 2/20 0.41
RAB9A P51151 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
KDM4E B2RXH2 1/20 0.41
MEN1 O00255 1/20 0.41
ALDH1A1 P00352 1/20 0.41
KMT2A Q03164 1/20 0.41
PLA2G2A P14555 4/20 0.39
PLA2G4A P47712 4/20 0.39
LMNA P02545 1/20 0.38
HSD17B1 P14061 1/20 0.38
HSD17B2 P37059 1/20 0.38
CDK1 P06493 3/20 0.38
CCNB1 P14635 3/20 0.38
CCNE1 P24864 3/20 0.38
CDK2 P24941 3/20 0.38
CCNE2 O96020 2/20 0.38
GSK3B P49841 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26161076 0.99 PLA2G2A (0.41) NPC1MAPTHPGDRAB9ASMN1; SMN2
SCHEMBL26161078 0.95 PLA2G2A (0.43) NPC1MAPTHPGDRAB9ASMN1; SMN2
SCHEMBL20176740 0.95 PLA2G2A (0.43) NPC1MAPTHPGDRAB9ASMN1; SMN2
SCHEMBL26160987 0.92 PLA2G2A (0.42) NPC1MAPTHPGDRAB9ASMN1; SMN2
SCHEMBL20176754 0.92 AHR (0.41) NPC1MAPTHPGDRAB9ASMN1; SMN2
SCHEMBL26161163 0.90 PLA2G2A (0.44) NPC1MAPTHPGDRAB9ASMN1; SMN2
SCHEMBL26161075 0.90 AHR (0.40) NPC1MAPTHPGDRAB9ASMN1; SMN2
SCHEMBL26160989 0.90 PLA2G2A (0.44) NPC1MAPTHPGDRAB9ASMN1; SMN2
SCHEMBL26161161 0.90 PLA2G2A (0.44) NPC1MAPTHPGDRAB9ASMN1; SMN2
SCHEMBL20176698 0.90 ESR1 (0.40) NPC1MAPTHPGDKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11667622-B2 Organic light emitting compound and organic electroluminescence device using same SOLUS ADVANCED MATERIALS CO., LTD. (KR) 2023-06-06 US disclosed
US-11667622-B2 Organic light emitting compound and organic electroluminescence device using same SOLUS ADVANCED MATERIALS CO., LTD. (KR) 2023-06-06 US disclosed
WO-2018093231-A1 ORGANIC LIGHT EMITTING COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING SAME 주식회사 두산 2018-05-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11667622-B2 Organic light emitting compound and organic electroluminescence device using same OR10J3, ICMT, SLCO4C1 NPC1 1168/4885MAPT 668/4885HPGD 3513/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.